Rep. Greg Stanton (D-AZ) Sells Trulieve Cannabis (TCNNF) Stock
U.S. Rep. Greg Stanton sold Trulieve Cannabis shares valued between $100,001 and $250,000.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Greg Stanton (D-AZ) sold between $100,001 and $250,000 of Trulieve Cannabis Corp. ($TCNNF) stock on May 28, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed June 26, 2026.
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Greg Stanton (D-AZ)
- Status:
- Member — House
- State/District:
- AZ-4
- Party:
- democrat
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Jun 26, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Trulieve Cannabis Corp. ($TCNNF) | Sell | May 28, 2026 | $100,001 - $250,000 |
Summary of the filed report, not the original document. Find the original: House financial disclosure search
TCNNF
Trulieve Cannabis Corp.
Key Points
- On May 28, 2026, Rep. Greg Stanton sold Trulieve Cannabis shares valued between $100,001 and $250,000.
- Trulieve Cannabis trades on the OTC Markets, with shares priced at $9.24 as of Wednesday.
- The company reported revenue of $1.17 billion and a net margin of -6.93% for the recent period.
Get $TCNNF trade alerts by text
We text you when insiders, Congress or big funds trade $TCNNF. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Trulieve Cannabis Corp. alert may contain errors. Disclosures
U.S. Representative Greg Stanton, a Democrat from Arizona's 4th district, sold shares of Trulieve Cannabis Corp. on May 28, 2026. The sale was valued between $100,001 and $250,000, according to his disclosure filed under the STOCK Act. This transaction was reported on June 26, 2026.
Greg Stanton vs. the S&P 500
Hypothetical returns from Greg Stanton's disclosed trades, not real profit or advice. How we model this.
Trulieve Cannabis Stock Snapshot
Shares of Trulieve Cannabis Corp. (OTC Markets: TCNNF) traded near $9.24 on Wednesday. The company has a market cap of approximately $1.89 billion. It is not profitable, as indicated by its negative earnings per share (EPS) of -$0.38. However, it has a forward P/E ratio of 41.04. Trulieve's stock has a 52-week low of $7.92 and a high of $13.28. The company's financial health shows a current ratio of 5.26 and a quick ratio of 3.01, with a debt-to-equity ratio of 54.80.
Recent Earnings
Trulieve Cannabis reported revenue of about $1.17 billion, though it faced a revenue decline of 3.7%. The company experienced a net margin of -6.93% and a return on equity of -6.85%. Investors are looking ahead to the next earnings report, expected on August 6, 2026.
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp. is a major player in the U.S. cannabis market, headquartered in Tallahassee, Florida. The company focuses on cultivating, processing, and selling cannabis products. Trulieve operates dispensaries across several states, including Florida, Arizona, and Pennsylvania. It offers a variety of products such as flowers, edibles, and vapes under various brand names. Led by CEO Kimberly Rivers, Trulieve employs around 5,000 people and continues to expand its footprint in the cannabis industry.
Bottom Line
Rep. Greg Stanton's recent sale of Trulieve Cannabis shares is a routine disclosure under the STOCK Act, reflecting transactions after they occur. Trulieve remains a significant player in the cannabis industry, with investors keeping an eye on its financial performance and future growth prospects. As always, these filings provide a snapshot of past activity and should not be considered current investment advice.
Related Filing Alerts
Source: Greg Stanton's STOCK Act disclosure on $TCNNF (May 28, 2026). Find the original filing: House financial disclosure search. Written by software, not financial advice. How we make alerts